Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models

MLA

Yuanjing Liu, et al. “Variant-Selective Stereopure Oligonucleotides Protect against Pathologies Associated with C9orf72-Repeat Expansion in Preclinical Models.” Nature Communications, vol. 12, no. 1, Feb. 2021, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41467-021-21112-8.

APA

Yuanjing Liu, Jean-Cosme Dodart, Helene Tran, Shaunna Berkovitch, Maurine Braun, Michael Byrne, Ann F. Durbin, Xiao Shelley Hu, Naoki Iwamoto, Hyun Gyung Jang, Pachamuthu Kandasamy, Fangjun Liu, Kenneth Longo, Jörg Ruschel, Juili Shelke, Hailin Yang, Yuan Yin, Amy Donner, Zhong Zhong, … Robert H. Brown. (2021). Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models. Nature Communications, 12(1), 1–15. https://doi.org/10.1038/s41467-021-21112-8

Chicago

Yuanjing Liu, Jean-Cosme Dodart, Helene Tran, Shaunna Berkovitch, Maurine Braun, Michael Byrne, Ann F. Durbin, et al. 2021. “Variant-Selective Stereopure Oligonucleotides Protect against Pathologies Associated with C9orf72-Repeat Expansion in Preclinical Models.” Nature Communications 12 (1): 1–15. doi:10.1038/s41467-021-21112-8.